12:00 AM
 | 
Apr 08, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Quartette levonorgestrel/ethinyl estradiol and ethinyl estradiol regulatory update

FDA approved an NDA from Teva for Quartette levonorgestrel/ethinyl estradiol and ethinyl estradiol oral contraceptive to prevent pregnancy. The tablets...

Read the full 77 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >